CHO-H01

· Cho Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHO-H01, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma [Phase 1, Phase 2]

See pricing